Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 50,970
- Estimated value
- $127,425
- Report date
- 14 Dec 2021
- Price
- $2.50
- Ownership
- Direct
Christopher David Ozeroff - S.V.P., General Counsel at Oruka Therapeutics, Inc.
Issuer-level insider activity
- Role
- S.V.P., General Counsel
- Issuer ticker
- ORKA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Christopher David Ozeroff since 20 Aug 2025
Reported holdings for Christopher David Ozeroff in Oruka Therapeutics, Inc.
Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 27,500
- Estimated value
- Report date
- 14 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Christopher David Ozeroff in Oruka Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.